Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

FGFR3-targeted antibody-drug conjugate

DRUG CLASS:

FGFR3-targeted antibody-drug conjugate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

FGFR3 overexpression	Bladder Cancer	FGFR3 overexpression	Bladder Cancer	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D
FGFR3 overexpression	Glioblastoma	FGFR3 overexpression	Glioblastoma	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D
FGFR3-TACC3 fusion	Bladder Cancer	FGFR3-TACC3 fusion	Bladder Cancer	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D
FGFR3-TACC3 fusion	Glioblastoma	FGFR3-TACC3 fusion	Glioblastoma	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D	AMB302 Sensitive: D – Preclinical AMB302 Sensitive : D
FGFR3-TACC3 fusion	Lung Cancer	FGFR3-TACC3 fusion	Lung Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D
FGFR3-TACC3 fusion	Bladder Cancer	FGFR3-TACC3 fusion	Bladder Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D
FGFR3-BAIAP2L1 fusion	Bladder Cancer	FGFR3-BAIAP2L1 fusion	Bladder Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D
FGFR3 R248C	Bladder Cancer	FGFR3 R248C	Bladder Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D
FGFR3 S249C	Bladder Cancer	FGFR3 S249C	Bladder Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D
FGFR3 G370C	Bladder Cancer	FGFR3 G370C	Bladder Cancer	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D	LY3076226 Sensitive: D – Preclinical LY3076226 Sensitive : D